SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001847903-24-000074
Filing Date
2024-04-26
Accepted
2024-04-26 16:36:04
Documents
7
Period of Report
2024-06-25

Document Format Files

Seq Description Document Type Size
1 PRE 14A centessapharmaceuticalsinc.htm PRE 14A 1027073
2 GRAPHIC a001a.jpg GRAPHIC 11267
3 GRAPHIC chart-1d8bd08c7894484c904a.jpg GRAPHIC 86060
4 GRAPHIC chart-9ba2a99a15404985b98a.jpg GRAPHIC 95162
5 GRAPHIC chart-a1c79955f0934458a69a.jpg GRAPHIC 76597
6 GRAPHIC picture1a.jpg GRAPHIC 4328
7 GRAPHIC proxyheader1a.jpg GRAPHIC 47810
  Complete submission text file 0001847903-24-000074.txt   1470652
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40445 | Film No.: 24884501
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)